Drug Type Oligonucleotide |
Synonyms Polydeoxyribonucleotides |
Target |
Action agonists |
Mechanism ERRFI1 agonists(ERBB receptor feedback inhibitor 1 agonists), NR4A1 agonists(nuclear receptor subfamily 4 group A member 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Skin aging | Discovery | - | - | 27 Mar 2026 |





